Contact this trialFirst, we need to learn more about you.
Small Molecule Kinase Inhibitor
Lapatinib + Trastuzumab for HER2 Positive Breast Cancer
Recruiting3 awardsPhase 2
Lancaster, California
This trial is studying how well lapatinib ditosylate and trastuzumab work in treating older patients with HER2-positive breast cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service